Vermont Latest State to Introduce Breast Density Inform Bill

Vermont, breast density inform law, mammograms, dense breast tissue

January 8, 2016 — The Vermont state Senate introduced a bill this week that would mandate healthcare facilities to share breast density information with patients following a mammogram. The resolution was introduced on the Senate floor Jan. 5 by Sen. Joe Benning (R-Caledonia) and referred to the Committee on Health and Welfare.

The resolution as introduced includes two provisions related to breast density. First, healthcare facilities that perform mammograms would be required to inform all patients who receive mammograms of their breast density classifications; classification would be based on the American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS). At the same time patients, with dense fibroglandular tissue must be notified that they may benefit from additional screening, as dense tissue and cancerous tissue both appear white on a mammogram, making detection more difficult.

If passed, the law would come into effect on July 1, 2016. That would make Vermont the 25th state to enact such a regulation. Louisiana was the last state to enact a breast density inform law, which was signed by Gov. Bobby Jindal last July and became effective Jan. 1 of this year.

For more information: www.densebreast-info.org

Related Content

VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing

News | Mammography | June 09, 2020

Volpara Solutions Helps Customers Resume Breast Screening Operations Amid COVID-19

June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State

In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.

Feature | Coronavirus (COVID-19) | June 09, 2020 | By Melinda Taschetta-Millane

Insight on the Impact of COVID-19 on Medical Imaging

Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020

Lunit INSIGHT MMG for Breast Cancer Detection Now CE Certified

June 2, 2020 — Lunit announced that its artificia...

AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.

The Exciting Future of AI and Mammography - and Physicians

Headlines around the world the past several months declared that...

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the x, y and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.